Trial intelligence / Profile preview

Effect of Stellate Ganglion Block on Postoperative Sleep in Prolonged Disorders of Consciousness

NCT07274683Not yet recruiting

Sponsor
Beijing Tiantan Hospital
Start
Oct 2026
Primary completion
Jul 2027
Countries
1
01

Overview

Open-label, single-arm trial of ropivacaine in Prolonged Disorders of Consciousness (PDOC), sponsored by Beijing Tiantan Hospital. Primary endpoint: Change in total sleep time. Planned start Oct 2026; status: not yet recruiting.

02

Drugs

ropivacaine
03

Conditions

Prolonged Disorders of Consciousness (PDOC)

Beyond the preview

Go deeper on NCT07274683.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07274683.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call